MX2021000719A - Composicion de microbiota fecal, para su uso en la reduccion de la inflamacion inducida por tratamiento. - Google Patents
Composicion de microbiota fecal, para su uso en la reduccion de la inflamacion inducida por tratamiento.Info
- Publication number
- MX2021000719A MX2021000719A MX2021000719A MX2021000719A MX2021000719A MX 2021000719 A MX2021000719 A MX 2021000719A MX 2021000719 A MX2021000719 A MX 2021000719A MX 2021000719 A MX2021000719 A MX 2021000719A MX 2021000719 A MX2021000719 A MX 2021000719A
- Authority
- MX
- Mexico
- Prior art keywords
- induced inflammation
- fecal microbiota
- reducing treatment
- microbiota composition
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/37—Digestive system
- A61K35/38—Stomach; Intestine; Goblet cells; Oral mucosa; Saliva
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Physiology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Developmental Biology & Embryology (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Rheumatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
La invención se refiere al uso de trasplante de microbiota fecal para prevenir y/o reducir la inflamación sistémica e intestinal inducida por tratamiento en un individuo que lo necesite.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP18305997.1A EP3597202A1 (en) | 2018-07-20 | 2018-07-20 | Fecal microbiota composition, for use in reducing treatment-induced inflammation |
PCT/FR2019/050522 WO2019171012A1 (fr) | 2018-03-09 | 2019-03-08 | Procédure de collecte de selles et procédé de préparation d'un échantillon pour transplantation de microbiote fécal |
PCT/EP2019/069597 WO2020016445A1 (en) | 2018-07-20 | 2019-07-19 | Fecal microbiota composition, for use in reducing treatment-induced inflammation |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2021000719A true MX2021000719A (es) | 2021-03-25 |
Family
ID=63144926
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2021000719A MX2021000719A (es) | 2018-07-20 | 2019-07-19 | Composicion de microbiota fecal, para su uso en la reduccion de la inflamacion inducida por tratamiento. |
Country Status (11)
Country | Link |
---|---|
US (1) | US20210299188A1 (es) |
EP (3) | EP3597202A1 (es) |
JP (1) | JP2021530527A (es) |
KR (1) | KR20210033984A (es) |
CN (1) | CN112399850A (es) |
AU (1) | AU2019304530A1 (es) |
BR (1) | BR112021000975A2 (es) |
CA (1) | CA3102488C (es) |
IL (1) | IL279282B1 (es) |
MX (1) | MX2021000719A (es) |
WO (1) | WO2020016445A1 (es) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111748640B (zh) * | 2020-04-22 | 2021-01-19 | 中国医学科学院北京协和医院 | 肠道菌群在肌少症中的应用 |
CN111944907B (zh) * | 2020-08-26 | 2022-12-27 | 山东大学齐鲁医院 | 粪杆菌作为急性髓性白血病诊断、预后或治疗标志物的应用 |
CN114045353B (zh) * | 2021-11-12 | 2022-09-27 | 中华人民共和国台州海关 | 与诺如病毒感染性腹泻相关的微生物标志物及其用途 |
CN114517231A (zh) * | 2022-03-03 | 2022-05-20 | 山东第一医科大学(山东省医学科学院) | 埃格特氏菌(Eggerthella lenta)的特异性引物、检测方法及试剂盒 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2013109251A (ru) * | 2010-08-04 | 2014-09-10 | Томас Джулиус БОРОДИ | Композиции для трансплантации фекальной флоры и способы их получения и применения и устройства для их доставки |
EP2876167A1 (en) * | 2013-11-21 | 2015-05-27 | Institut Gustave Roussy | Microbiota composition, as a marker of responsiveness to chemotherapy, and use of microbial modulators (pre-,pro- or synbiotics) for improving the efficacy of a cancer treatment |
AU2015353465B2 (en) * | 2014-11-25 | 2021-07-29 | Memorial Sloan-Kettering Cancer Center | Intestinal microbiota and GVHD |
RU2017134547A (ru) * | 2015-04-23 | 2019-04-09 | Калейдо Байосайенсиз, Инк. | Регуляторы микробиома и соответствующие варианты их применения |
FR3035328B1 (fr) * | 2015-04-24 | 2019-08-23 | Maat Pharma | Procede de preparation d'un echantillon de microbiote fecal |
FR3035317B1 (fr) | 2015-04-24 | 2019-06-14 | Maat Pharma | Dispositif de prelevement de micro-organismes, kit de prelevement comprenant un tel dispositif et procede de prelevement mettant en œuvre un tel dispositif |
TW201717975A (zh) * | 2015-06-01 | 2017-06-01 | 美國芝加哥州立大學 | 藉由控制共生微生物叢來治療癌症 |
FR3045383B1 (fr) | 2015-12-18 | 2019-06-14 | Maat Pharma | Procede de lyophilisation d'un echantillon de microbiote fecal |
US20190032004A1 (en) * | 2016-07-28 | 2019-01-31 | Bobban Subhadra | Devices, systems and methods for the production of humanized gut commensal microbiota |
US20180036352A1 (en) * | 2016-08-03 | 2018-02-08 | Crestovo Holdings Llc | Methods for treating ulcerative colitis |
-
2018
- 2018-07-20 EP EP18305997.1A patent/EP3597202A1/en not_active Ceased
-
2019
- 2019-07-19 BR BR112021000975-2A patent/BR112021000975A2/pt unknown
- 2019-07-19 MX MX2021000719A patent/MX2021000719A/es unknown
- 2019-07-19 IL IL279282A patent/IL279282B1/en unknown
- 2019-07-19 EP EP19745077.8A patent/EP3823650A1/en active Pending
- 2019-07-19 JP JP2021502751A patent/JP2021530527A/ja active Pending
- 2019-07-19 KR KR1020217001360A patent/KR20210033984A/ko unknown
- 2019-07-19 WO PCT/EP2019/069597 patent/WO2020016445A1/en unknown
- 2019-07-19 US US17/261,532 patent/US20210299188A1/en active Pending
- 2019-07-19 EP EP24174149.5A patent/EP4389209A2/en active Pending
- 2019-07-19 AU AU2019304530A patent/AU2019304530A1/en active Pending
- 2019-07-19 CA CA3102488A patent/CA3102488C/en active Active
- 2019-07-19 CN CN201980047146.2A patent/CN112399850A/zh active Pending
Also Published As
Publication number | Publication date |
---|---|
IL279282B1 (en) | 2024-03-01 |
BR112021000975A2 (pt) | 2021-04-20 |
WO2020016445A1 (en) | 2020-01-23 |
CN112399850A (zh) | 2021-02-23 |
CA3102488C (en) | 2024-01-02 |
KR20210033984A (ko) | 2021-03-29 |
AU2019304530A1 (en) | 2021-01-07 |
CA3102488A1 (en) | 2020-01-23 |
EP4389209A2 (en) | 2024-06-26 |
US20210299188A1 (en) | 2021-09-30 |
EP3823650A1 (en) | 2021-05-26 |
IL279282A (en) | 2021-01-31 |
EP3597202A1 (en) | 2020-01-22 |
JP2021530527A (ja) | 2021-11-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2021000719A (es) | Composicion de microbiota fecal, para su uso en la reduccion de la inflamacion inducida por tratamiento. | |
PH12020500240A1 (en) | Anti-cd39 antibodies, compositions comprising anti-cd39 antibodies and methods of using anti-cd39 antibodies | |
PH12016501099A1 (en) | Materials and methods for controlling infections | |
EP3701041A4 (en) | METHODS AND COMPOSITIONS FOR TREATING DISEASES ASSOCIATED WITH DEPLETED T-LYMPHOCYTES | |
NZ730865A (en) | Peptides having anti-inflammatory properties | |
MX2015011898A (es) | Compuestos de pirazolo y usos de los mismos. | |
MX2019015311A (es) | Composiciones de ésteres de ácido cannabidiólico y usos de las mismas. | |
NZ720769A (en) | Anti-siglec-8 antibodies and methods of use thereof | |
PH12019501323A1 (en) | Compositions comprising sulfated polysaccharides | |
MX2017014245A (es) | Composiciones que comprenden celulas germinales mesenquimales y usos de las mismas. | |
EP4378535A3 (en) | Antibiotic formulations for lower back pain | |
PH12021550611A1 (en) | Interleukin 10 Conjugates and Uses Thereof | |
PH12021551100A1 (en) | Dried biological compositions and methods thereof | |
CR20200275A (es) | Hidroxiisoxazolinas y derivados de estos | |
EP3860619A4 (en) | COMPOSITIONS AND METHODS FOR TREATING PATHOGENIC INFECTIONS IN PLANTS | |
MX2018007871A (es) | Composiciones para el cuidado personal. | |
MX369223B (es) | Composiciones de protector solar. | |
MY191930A (en) | Microbial lysozyme for use in the treatment of irritable bowel syndrome or inflammatory bowel disease | |
EP3808357A4 (en) | COMPOSITION AND USES THEREOF | |
MX2019009759A (es) | Composiciones de peptido estables. | |
GB2543723A (en) | Polyphenol compositions | |
NZ738876A (en) | Motile sperm domain containing protein 2 and inflammation | |
CR20210021A (es) | Apirasas solubilizadas, métodos y usos | |
MX2020011027A (es) | Constructos de anticuerpos biespecíficos trivalentes. | |
EP3793542A4 (en) | TERPENE-ENRICHED CANNABINOID COMPOSITIONS AND THEIR USES IN THE TREATMENT OF INFECTIOUS DISEASES |